LifeSciencePLUS PRESS RELEASE
December 5, 2013
LifeScience PLUS announced today that it has acquired exclusive patent rights to US and corresponding foreign patents covering water-soluble, oxidized - etherified regenerated cellulose materials. CEO and President of LifeScience PLUS, Vicky Feng, said today that while her company has for several years sold its Hemostatic BloodSTOP and BloodSTOP iX wound care products under license from the original owners of US Patent 7,262,181 which was granted in 2007, the company has been successful in negotiating an exclusive license with full rights to sub-license and otherwise enforce the patents worldwide. She further indicated that her company is considering the implementation of an industry-wide licensing program intended to insure that all covered products sold by the company's licensees are manufactured and marketed in accordance with the highest possible safety standards.
LifeSciencePLUS, Inc., is pleased to announce the recertification of its Class IIb CE Mark Certification for the BloodSTOP® line of topical hemostats. The recertification has been extended to include bleeding control for people on anti-coagulant medications.
UCSF preclinical study done in conjunction with University Hospital Pellegrin in France shows BloodSTOP iX® controls bleeding up to three times faster than Gelfoam® or Surgicel®.
A preclinical study performed in accordance with GLP guidelines, tested BloodSTOP and BloodSTOP iX on a group of animals receiving anticoagulant drugs against a control subject that received none. Tests showed hemostasis was achieved in the anticoagulant group in a time that was statistically significant and comparable to that of the control subject.
LifeScience PLUS, Inc., announces today that it has partnered with Medline Industries for the launch of Curad® BloodSTOP and Walgreens® Blood Barrier Hemostat Gauze with its BloodSTOP technology.
Watch the news story which covered BloodSTOP products from ABC7 News, KGO-TV, San Francisco.
LifeScience PLUS, Inc., announces today that it has signed a store brand agreement for the supply of its proprietary hemostat technology to CVS.
LifeScience PLUS has donated $43,000 worth of BloodSTOP products to the Haiti earthquake relief effort through theCatholic Medical Mission Board for the medical treatment of wounds sustained in the recent crisis.
Kerr Drug has brought a new bleeding control solution to their market with the introduction of BloodSTOP®Hemostatic Gauze, manufactured by LifeScience PLUS.
Watch a video of BloodSTOP being featured on Fox News.
Watch the video of BloodSTOP on CBS News.
LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® iX Absorbable Hemostat has been granted the Class III CE Mark certification for internal wounds. Already in medical markets overseas as a surface wound hemostat, BloodSTOP® iX will now be offered to the internal, surgical market in Europe.
LifeScience PLUS today announced the introduction of its proven fast-acting BloodSTOP hemostatic products in global markets. The company's patent pending hemostatic technology brings a new level of efficacy to the wound care market.
LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® has been granted the Class IIb CE Mark certification for the control of bleeding from all surface wounds. “We are pleased to be able to extend our markets for this breakthrough product beyond the US and into the European markets,” said Vicky Feng, President and CEO.
BloodSTOP®, a 100% natural fiber cellulose gauze which quickly stops bleeding, has now been cleared by FDA for marketing to consumers. BloodSTOP®, initially used by Medical Professionals to effectively manage blood loss and speed up healing, has now been designed for the consumer and is available at drug stores.
Dr. Joe Blaes, DDS, reports on BloodSTOP®.
Dr. George Fredman, DDS, gives his impressions of BloodSTOP® based on his clinical experience.